Bio-Rad Laboratories, Inc. (BIO)
247.53
+1.26
(+0.51%)
USD |
NYSE |
May 15, 16:00
247.64
+0.11
(+0.04%)
After-Hours: 20:00
Bio-Rad Laboratories EPS Diluted (Quarterly) : -19.55 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.074 |
| Bruker Corp. | 0.0229 |
| Azenta, Inc. | -3.491 |
| Harvard Bioscience, Inc. | -0.7655 |
| Revvity, Inc. | 0.364 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -527.10M |
| Revenue (Quarterly) | 592.10M |
| Total Expenses (Quarterly) | 1.119B |
| Enterprise Value | 6.436B |
| Gross Profit Margin (Quarterly) | 52.25% |
| Profit Margin (Quarterly) | -89.02% |
| Earnings Yield | 2.45% |
| Operating Earnings Yield | 3.62% |
| Normalized Earnings Yield | 3.093 |